We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
-1.29%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$664M
AUM Growth
-$538M
(-45%)
Cap. Flow
-$484M
Cap. Flow
% of AUM
-72.87%
Top 10 Holdings %
Top 10 Hldgs %
25.32%
Holding
142
New
15
Increased
24
Reduced
58
Closed
34
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Certara
CERT
|
+$11.8M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$11.4M |
| 3 |
Privia Health
PRVA
|
+$10M |
| 4 |
Definitive Healthcare
DH
|
+$9.98M |
| 5 |
Arrowhead Research
ARWR
|
+$7.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Agilent Technologies
A
|
+$17.9M |
| 2 |
Arcus Biosciences
RCUS
|
+$17.7M |
| 3 |
ResMed
RMD
|
+$15.8M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$14.5M |
| 5 |
Evolent Health
EVH
|
+$13.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.16% |
| 2 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Certara
CERT
$1.21B
| $9.96M | 1.5% |
+350,438
| New | +$11.8M |
|
27
Abbott
ABT
$183B
| $9.65M | 1.45% |
68,548
-5,900
| -8% | -$755K |
|
28
Health Catalyst
HCAT
$154M
| $9.58M | 1.44% |
241,739
-199,261
| -45% | -$9.08M |
|
29
AbbVie
ABBV
$455B
| $9.32M | 1.4% |
68,800
-20,200
| -23% | -$2.39M |
|
|
SILK
30
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $8.9M | 1.34% |
209,000
-215,500
| -51% | -$10.8M |
|
31
Intellia Therapeutics
NTLA
$1.55B
| $8.47M | 1.27% |
71,600
+8,700
| +14% | +$1.09M |
|
32
Denali Therapeutics
DNLI
$3.86B
| $8.46M | 1.27% |
189,600
+62,100
| +49% | +$2.94M |
|
33
Rocket Pharmaceuticals
RCKT
$351M
| $8.36M | 1.26% |
382,975
-123,110
| -24% | -$3.36M |
|
34
Eli Lilly
LLY
$1.03T
| $8.14M | 1.22% |
29,465
-11,250
| -28% | -$2.85M |
|
|
35
Definitive Healthcare
DH
$75.7M
| $7.8M | 1.17% |
+285,299
| New | +$9.98M |
|
36
TG Therapeutics
TGTX
$8.19B
| $7.6M | 1.14% |
399,949
+5,000
| +1% | +$130K |
|
37
Exelixis
EXEL
$14.1B
| $7.49M | 1.13% |
409,940
+26,570
| +7% | +$508K |
|
|
BPMC
38
DELISTED
Blueprint Medicines
BPMC
| $7.05M | 1.06% |
+65,800
| New | +$6.88M |
|
|
39
Arrowhead Research
ARWR
$12.3B
| $6.95M | 1.05% |
+104,800
| New | +$7.2M |
|
40
Novavax
NVAX
$1.22B
| $6.34M | 0.95% |
44,300
-45,150
| -50% | -$7.76M |
|
|
NVTA
41
DELISTED
Invitae Corporation
NVTA
| $6.27M | 0.94% |
410,763
| – | – |
|
|
SWAV
42
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $6.24M | 0.94% |
35,000
+7,000
| +25% | +$1.38M |
|
|
EXAI
43
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $5.96M | 0.9% |
+301,433
| New | +$6.33M |
|
|
BLU
44
DELISTED
BELLUS Health Inc.
BLU
| $5.81M | 0.87% |
721,966
-1,216,938
| -63% | -$8.08M |
|
|
SGEN
45
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.71M | 0.86% |
36,930
-61,176
| -62% | -$10.2M |
|
46
STAAR Surgical
STAA
$1.21B
| $5.71M | 0.86% |
62,500
+15,200
| +32% | +$1.63M |
|
47
Boston Scientific
BSX
$68.4B
| $5.53M | 0.83% |
130,226
+4,250
| +3% | +$179K |
|
48
Danaher
DHR
$138B
| $5.52M | 0.83% |
18,922
| – | – |
|
49
Align Technology
ALGN
$12.4B
| $5.43M | 0.82% |
8,265
-10,510
| -56% | -$6.76M |
|
|
CELL
50
DELISTED
PhenomeX Inc. Common Stock
CELL
| $5.31M | 0.8% |
291,835
-129,700
| -31% | -$2.8M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, Sectoral Asset Management held 142 positions worth $664M, down 45% from $1.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Sectoral Asset Management withdrew a net $484M in Q4 2021, closing 34 positions and reducing 58 holdings. Its most notable exit was ResMed, an estimated $15.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 95% a quarter earlier, followed by Industrials.
Against the trend, Sectoral Asset Management opened a new position in Certara worth $9.96M.
- Sectoral Asset Management's largest Q4 2021 buy was Certara: 350,438 shares worth $9.96M.
- Sectoral Asset Management added most to Mirati Therapeutics, Inc. Common Stock in Q4 2021, an estimated $11.4M increase.
- Sectoral Asset Management's biggest Q4 2021 reduction was Agilent Technologies, cutting an estimated $17.9M.
- Sectoral Asset Management fully exited ResMed in Q4 2021, selling an estimated $15.8M.
- Sectoral Asset Management's ten largest holdings make up 25% of its $664M portfolio in Q4 2021.
- Sectoral Asset Management opened 15 new positions and closed 34 in Q4 2021.
- Sectoral Asset Management's portfolio value fell 45% quarter-over-quarter to $664M.
Based on Sectoral Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.